Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-04-14 Sale |
2021-04-15 5:55 pm |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
500 | $42.82 | $21,410 | 56,214 (Direct) |
View |
2021-04-01 Sale |
2021-04-05 5:11 pm |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
600 | $43.41 | $26,046 | 56,714 (Direct) |
View |
2021-03-15 Sale |
2021-03-17 4:16 pm |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
2,500 | $46.77 | $116,925 | 821,523 (Indirect Direct) |
View |
2021-03-15 Sale |
2021-03-17 4:14 pm |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
500 | $46.77 | $23,385 | 57,314 (Direct) |
View |
2021-03-10 Sale |
2021-03-11 4:08 pm |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
6,250 | $50.74 | $317,125 | 1,257,336 (Direct) |
View |
2021-03-05 Sale |
2021-03-08 4:32 pm |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
5,000 | $48.62 | $243,075 | 91,887 (Direct) |
View |
2021-03-01 Sale |
2021-03-03 4:05 pm |
Apellis Pharmaceuticals Inc. | APLS | Perry Nicole D Vice President - Accounting |
2,000 | $50 | $100,000 | 13,508 (Direct) |
View |
2021-03-01 Sale |
2021-03-03 4:03 pm |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
600 | $48.58 | $29,148 | 57,814 (Direct) |
View |
2021-02-16 Sale |
2021-02-17 4:12 pm |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
500 | $46 | $23,000 | 58,414 (Direct) |
View |
2021-02-16 Sale |
2021-02-17 4:11 pm |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
2,500 | $46 | $115,000 | 824,023 (Indirect Direct) |
View |
2021-02-09 Sale |
2021-02-10 4:37 pm |
Apellis Pharmaceuticals Inc. | APLS | Perry Nicole D Vice President - Accounting |
2,000 | $50 | $100,000 | 15,661 (Direct) |
View |
2021-02-01 Sale |
2021-02-02 4:08 pm |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
600 | $44 | $26,400 | 59,602 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2021-04-09 4:04 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Senior Vice President |
0 | $0 | 137,448 (Direct) |
View |
2021-03-25 Tax Withholding |
2021-03-29 4:58 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Brown Victoria L. Program Team Lead |
82 | $41.16 | 9,952 (Direct) |
View |
2021-03-22 Exercise |
2021-03-23 4:14 pm |
N/A 2027-08-20 |
Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel |
978 | $0 | 109,193 (Direct) |
View |
2021-03-22 Exercise |
2021-03-23 4:14 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel |
978 | $4.31 | 109,193 (Direct) |
View |
2021-03-01 Option Award |
2021-03-19 5:58 pm |
N/A 2031-02-28 |
Apellis Pharmaceuticals Inc. | APLS | Brown Victoria L. Program Team Lead |
8,750 | $0 | 17,534 (Direct) |
View |
2021-03-15 Exercise |
2021-03-17 4:16 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
2,500 | $2.67 | 821,523 (Direct) |
View |
2021-03-15 Exercise |
2021-03-17 4:16 pm |
N/A 2023-12-04 |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
2,500 | $0 | 821,523 (Direct) |
View |
2021-03-10 Exercise |
2021-03-11 4:08 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
6,250 | $2.67 | 1,257,336 (Direct) |
View |
2021-03-10 Exercise |
2021-03-11 4:08 pm |
N/A 2023-12-05 |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
6,250 | $0 | 1,257,336 (Direct) |
View |
2021-03-05 Exercise |
2021-03-08 4:32 pm |
N/A 2024-12-12 |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
5,000 | $0 | 91,887 (Direct) |
View |
2021-03-05 Exercise |
2021-03-08 4:32 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
5,000 | $3.2 | 91,887 (Direct) |
View |
2021-03-01 Option Award |
2021-03-03 4:07 pm |
N/A 2031-02-28 |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Exec VP, Program Team Lead |
8,750 | $0 | 14,961 (Direct) |
View |
2021-03-01 Exercise |
2021-03-03 4:05 pm |
N/A 2025-07-31 |
Apellis Pharmaceuticals Inc. | APLS | Perry Nicole D Vice President - Accounting |
2,000 | $0 | 13,508 (Direct) |
View |
2021-03-01 Exercise |
2021-03-03 4:05 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Perry Nicole D Vice President - Accounting |
2,000 | $3.76 | 13,508 (Direct) |
View |
2021-02-16 Exercise |
2021-02-17 4:11 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
2,500 | $2.67 | 824,023 (Direct) |
View |
2021-02-16 Exercise |
2021-02-17 4:11 pm |
N/A 2023-12-04 |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
2,500 | $0 | 824,023 (Direct) |
View |
2021-02-10 Tax Withholding |
2021-02-11 4:18 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | SCHEIBLER LUKAS CHIEF INNOVATION OFFICER |
680 | $47.72 | 29,290 (Direct) |
View |
2021-02-10 Tax Withholding |
2021-02-11 4:16 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
858 | $47.72 | 34,261 (Direct) |
View |
2021-02-10 Tax Withholding |
2021-02-11 4:14 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Perry Nicole D Vice President - Accounting |
153 | $47.72 | 2,347 (Direct) |
View |
2021-02-10 Tax Withholding |
2021-02-11 4:12 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
688 | $47.72 | 865,087 (Direct) |
View |
2021-02-10 Tax Withholding |
2021-02-11 4:10 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
688 | $47.72 | 18,865 (Direct) |
View |
2021-02-10 Tax Withholding |
2021-02-11 4:07 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Brown Victoria L. Program Team Lead |
144 | $47.72 | 8,784 (Direct) |
View |
2021-02-10 Tax Withholding |
2021-02-11 4:06 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
688 | $47.72 | 58,914 (Direct) |
View |
2021-02-10 Tax Withholding |
2021-02-11 4:05 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
2,523 | $47.72 | 1,454,244 (Direct) |
View |
2021-02-10 Tax Withholding |
2021-02-11 4:02 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel |
468 | $47.72 | 105,794 (Direct) |
View |
2021-02-09 Exercise |
2021-02-10 4:37 pm |
N/A 2025-07-31 |
Apellis Pharmaceuticals Inc. | APLS | Perry Nicole D Vice President - Accounting |
2,000 | $0 | 15,661 (Direct) |
View |
2021-02-09 Exercise |
2021-02-10 4:37 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Perry Nicole D Vice President - Accounting |
2,000 | $3.76 | 15,661 (Direct) |
View |
Ownership |
2021-02-04 7:17 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
0 | $0 | 1,347,490 (Indirect) |
View |
2020-12-29 Ownership |
2021-02-04 7:17 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
300,000 | $0 | 1,347,490 (Direct) |
View |
Ownership |
2021-02-04 7:13 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
0 | $0 | 671,494 (Indirect) |
View |
2020-12-02 Ownership |
2021-02-04 7:13 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Machiels Alec Director |
250,000 | $0 | 671,494 (Direct) |
View |
2021-01-28 Option Award |
2021-02-01 4:44 pm |
N/A 2031-01-27 |
Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer |
65,625 | $0 | 75,803 (Direct) |
View |
2021-01-28 Option Award |
2021-02-01 4:43 pm |
N/A 2031-01-27 |
Apellis Pharmaceuticals Inc. | APLS | Grossi Federico CHIEF MEDICAL OFFICER |
65,625 | $0 | 116,452 (Direct) |
View |
2021-01-28 Option Award |
2021-02-01 4:42 pm |
N/A 2031-01-27 |
Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer |
262,500 | $0 | 1,681,767 (Direct) |
View |
2021-01-28 Option Award |
2021-02-01 4:42 pm |
N/A 2031-01-27 |
Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer |
78,750 | $0 | 102,619 (Direct) |
View |
2021-01-28 Option Award |
2021-02-01 4:40 pm |
N/A 2031-01-27 |
Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel |
65,625 | $0 | 162,512 (Direct) |
View |
2021-01-28 Option Award |
2021-02-01 4:39 pm |
N/A 2031-01-27 |
Apellis Pharmaceuticals Inc. | APLS | SCHEIBLER LUKAS CHIEF INNOVATION OFFICER |
65,625 | $0 | 86,220 (Direct) |
View |
2021-01-28 Option Award |
2021-02-01 4:38 pm |
N/A 2031-01-27 |
Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer |
65,625 | $0 | 65,625 (Direct) |
View |
2021-01-28 Option Award |
2021-02-01 4:37 pm |
N/A 2031-01-27 |
Apellis Pharmaceuticals Inc. | APLS | Lewis Karen Chief People Officer |
43,750 | $0 | 43,750 (Direct) |
View |
2021-01-28 Option Award |
2021-02-01 4:36 pm |
N/A 2031-01-27 |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Exec VP, Program Team Lead |
35,000 | $0 | 36,211 (Direct) |
View |
2021-01-28 Option Award |
2021-02-01 4:35 pm |
N/A 2031-01-27 |
Apellis Pharmaceuticals Inc. | APLS | Brown Victoria L. Program Team Lead |
35,000 | $0 | 38,928 (Direct) |
View |
2021-01-28 Option Award |
2021-02-01 4:35 pm |
N/A 2031-01-27 |
Apellis Pharmaceuticals Inc. | APLS | Perry Nicole D Vice President - Accounting |
17,500 | $0 | 17,500 (Direct) |
View |
2021-01-28 Option Award |
2021-02-01 4:34 pm |
N/A 2031-01-27 |
Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer |
65,625 | $0 | 922,025 (Direct) |
View |